Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-07-12 @ 12:37 AM
Study NCT ID:
NCT04736966
Status:
COMPLETED
Last Update Posted:
2024-08-06
First Post:
2021-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease
Sponsor:
University of California, San Diego
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Anti-IL23 Trial Phase 1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None